Medications

'Magic mushroom' drug edges toward mainstream therapy

(HealthDay)—Tony Head was depressed and fearing death from stage 4 prostate cancer when, as part of a supervised scientific trial, he took a large dose of the psychedelic agent in "magic mushrooms," psilocybin.

Oncology & Cancer

New drug for metastatic colorectal cancer enters phase 3 trial

A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.

Diseases, Conditions, Syndromes

Search for COVID-19 drugs boosted by SARS discovery

An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.

Diseases, Conditions, Syndromes

Nanobodies hold the key to imaging COVID-19

Researchers from Protein Production UK, a collaborative project led by The Rosalind Franklin Institute, have isolated nanobodies—a type of antibody used in research, which bind to the 'spike' protein of the SARS-CoV-2 virus.

Oncology & Cancer

Turning on the 'off switch' in cancer cells

A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway ...

page 10 from 40